Share-based Payment Arrangement, Expense of Citius Pharmaceuticals, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Citius Pharmaceuticals, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • Citius Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $2,547,673, a 28% decline year-over-year.
  • Citius Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $10,836,291, unchanged year-over-year.
  • Citius Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $10,836,291, unchanged from 2024.
  • Citius Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $10,836,291, a 64% increase from 2023.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Citius Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $10,836,291 $2,547,673 -$977,930 -28% 01 Jul 2025 30 Sep 2025 10-K 23 Dec 2025 2025 FY
Q2 2025 $11,814,221 $3,061,763 +$1,887,652 +161% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q3
Q1 2025 $9,926,569 $2,702,031 -$376,361 -12% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q2
Q4 2024 $10,302,930 $2,524,824 -$533,361 -17% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025 2025 Q1
Q3 2024 $10,836,291 $3,525,603 01 Jul 2024 30 Sep 2024 10-K 23 Dec 2025 2025 FY
Q2 2024 $1,174,111 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2024 2024 Q3
Q1 2024 $3,078,392 +$1,912,797 +164% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q2
Q4 2023 $3,058,185 +$1,857,104 +155% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025 2025 Q1
Q1 2023 $1,165,595 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q2
Q4 2022 $1,201,081 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q1

Citius Pharmaceuticals, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $10,836,291 $0 0% 01 Oct 2024 30 Sep 2025 10-K 23 Dec 2025 2025 FY
2024 $10,836,291 +$4,219,586 +64% 01 Oct 2023 30 Sep 2024 10-K 23 Dec 2025 2025 FY
2023 $6,616,705 01 Oct 2022 30 Sep 2023 10-K 27 Dec 2024 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.